Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Hackert

Showing results (361-370 of 631) with videos related to

Pageof 64
Sort By:
Annals of Surgery|May 10, 2023
Systematic Review and Meta-analysis of the Role of Total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: Is it a Justifiable Indication?Thomas F Stoop, Erik Bergquist, Rutger T Theijse, et al.
Annals of Surgical Oncology|December 13, 2025
ASO Visual Abstract: Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) after Pancreatic Cancer Resection: A Retrospective Cohort StudyCarl-Stephan Leonhardt, Sakher Shraim, Karim Abdelazim, et al.
Cancers|January 5, 2021
Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor HypoxiaPhilipp Mayer, Anne Kraft, Hagen R Witzel, et al.
Annals of Surgery|March 29, 2019
Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic CancerUlla Klaiber, Eva S Schnaidt, Ulf Hinz, et al.
Annals of Surgical Oncology|November 22, 2025
Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) After Pancreatic Cancer Resection: A Retrospective Cohort StudyCarl-Stephan Leonhardt, Sakher Shraim, Karim Abdelazim, et al.
Surgery|January 2, 2021
Not all Whipple procedures are equal: Proposal for a classification of pancreatoduodenectomiesAndre L Mihaljevic, Thilo Hackert, Martin Loos, et al.
Cell Death & Disease|October 6, 2017
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1Li Liu, Ewa Aleksandrowicz, Frank Schönsiegel, et al.
International Journal of Colorectal Disease|May 25, 2026
Impact of socioeconomic status on patient characteristics and postoperative outcomes in colorectal cancer surgery: A retrospective cohort studyNina Schraps, Amani Nassar, Siwen Zhang, et al.
Nature Medicine|October 20, 2015
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progressionMuhammad S Alam, Matthias M Gaida, Frank Bergmann, et al.
Langenbeck'S Archives of Surgery|July 9, 2021
Technical progress in robotic pancreatoduodenectomy: TRIANGLE and periadventitial dissection for retropancreatic nerve plexus resectionBenedict Kinny-Köster, Joseph R Habib, Ammar A Javed, et al.
Pageof 64

Showing results (361-370 of 631) with videos related to

Sort By:
Pageof 64
Annals of Surgery|May 10, 2023
Systematic Review and Meta-analysis of the Role of Total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: Is it a Justifiable Indication?Thomas F Stoop, Erik Bergquist, Rutger T Theijse, et al.
Annals of Surgical Oncology|December 13, 2025
ASO Visual Abstract: Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) after Pancreatic Cancer Resection: A Retrospective Cohort StudyCarl-Stephan Leonhardt, Sakher Shraim, Karim Abdelazim, et al.
Cancers|January 5, 2021
Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor HypoxiaPhilipp Mayer, Anne Kraft, Hagen R Witzel, et al.
Annals of Surgery|March 29, 2019
Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic CancerUlla Klaiber, Eva S Schnaidt, Ulf Hinz, et al.
Annals of Surgical Oncology|November 22, 2025
Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) After Pancreatic Cancer Resection: A Retrospective Cohort StudyCarl-Stephan Leonhardt, Sakher Shraim, Karim Abdelazim, et al.
Surgery|January 2, 2021
Not all Whipple procedures are equal: Proposal for a classification of pancreatoduodenectomiesAndre L Mihaljevic, Thilo Hackert, Martin Loos, et al.
Cell Death & Disease|October 6, 2017
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1Li Liu, Ewa Aleksandrowicz, Frank Schönsiegel, et al.
International Journal of Colorectal Disease|May 25, 2026
Impact of socioeconomic status on patient characteristics and postoperative outcomes in colorectal cancer surgery: A retrospective cohort studyNina Schraps, Amani Nassar, Siwen Zhang, et al.
Nature Medicine|October 20, 2015
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progressionMuhammad S Alam, Matthias M Gaida, Frank Bergmann, et al.
Langenbeck'S Archives of Surgery|July 9, 2021
Technical progress in robotic pancreatoduodenectomy: TRIANGLE and periadventitial dissection for retropancreatic nerve plexus resectionBenedict Kinny-Köster, Joseph R Habib, Ammar A Javed, et al.
Pageof 64